摘要
目的探讨C反应蛋白(CRP)在慢性阻塞性肺疾病急性加重期的临床意义及痰热清注射液治疗前后CRP的变化。方法比较80例慢性阻塞性肺疾病患者急性加重期及稳定期的CRP和WBC总数的变化。并随机分为给予基础治疗的对照组40例和加用痰热清注射液治疗的治疗组40例,比较治疗前后两组CRP的变化。结果AECOPD患者CRP水平显著高于稳定期患者(P<0.05),治疗后对照组CRP水平显著高于痰热清治疗组(P<0.05)。结论CRP可作为慢性阻塞性肺疾病急性加重期的预测因子,痰热清注射液抗炎的作用明显,可用于慢性阻塞性肺疾病急性加重期的治疗。
Objective To discuss the clinical significance of C-reactive protein （CRP）in acute exacerbation of chronic obstructive pulmonary disease （AECOPD） and the changes of CRP before and after treatment with Tanreqing injection. Methods CRP and WBC were compared in the acute exacerbation and the stable stage of 80 cases of COPD which were randomly divided into control group of 40 cases given foundation treatment and treatment group of 40 cases given Tanreqing injection besides foundation treatment. CRP change was compared before and after treatment. Results The CRP level in AECOPD was significantly higher than that in stable COPD （P〈 0.05）. The CRP level in the control group was higher than that in the treatment group（P〈 0.05 ）. Conclusion CRP is a predictor of AECOPD. The anti-inflammation function of Tanreqing is obvious and Tanreqing injection is available in treatment of AECOPD.
出处
《中国现代医生》
2009年第24期93-94,共2页
China Modern Doctor
